IP Library Granted Patent US 12,234,450
Granted Patent B2
US 12,234,450 · App. 17/200,633 · Granted Feb 25, 2025

Generation of synthetic genomes

Inventors: Clyde A. Hutchison (La Jolla, CA); Ray-Yuan Chuang (Rockville, MD); Vladimir N. Noskov (Gaithersburg, MD); Bogumil J. Karas (London, CA); Kim S. Wise (San Diego, CA); Hamilton O. Smith (San Diego, CA); John I. Glass (San Diego, CA); Chuck Merryman (Encinitas, CA); Daniel G. Gibson (Carlsbad, CA); J. Craig Venter (La Jolla, CA); Krishna Kannan (San Diego, CA); Lin Ding (San Diego, CA)
C12N15/1027C12N15/1058C12N15/1079C12N15/1093C12N15/74C12N15/81G16B30/00G16B30/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,234,450
App. No.
17/200,633
Granted
Feb 25, 2025
Kind
B2
Abstract

Methods for generating synthetic genomes, for example synthetic genomes having desired properties or viable genomes of reduced size, are disclosed. Also disclosed are synthetic genomes produced by the methods disclosed herein and synthetic cells containing the synthetic genomes disclosed herein.

Claims (26)

1. A method for generating a synthetic genome of interest, comprising:

(a) providing a first genome sufficient to sustain viability of a prokaryotic cell;

(b) designing and providing a second genome comprising a reduced number of genes compared to the first genome;

(c) dividing each of the first and second genomes into at least three corresponding fragments;

(d) combining at least one fragment of the second genome with fragments of the first genome to generate a third genome having all the at least three corresponding fragments, further comprising grouping genes related to the same biological process in at least one fragment of the second genome prior to combining; or grouping genes related to the same biological process in the third genome after combining;

(e) testing the third genome generated in step (d) for sufficiency to sustain viability of a cell; and

(f) identifying the third genome as a synthetic genome of interest if it sustains viability of the prokaryotic cell; otherwise genetically modifying the at least one fragment of the second genome and repeating steps (d)-(f) in one or more iterations until a genome that sustains viability of the prokaryotic cell is obtained in the third genome.

2. The method of claim 1 , wherein the first genome is a Mycoplasma genome.

3. The method of claim 1 , wherein the first genome is a multi-chromosome genome.

4. The method of claim 1 , wherein step (b) further comprises testing the second genome for a set of desired properties selected from the group consisting of: growth rate, ratio of growth rate to genome size, expression level of a gene of interest, ratio of viability to genome size, ratio of viability to expression level of a gene of interest, and ratio of growth rate to expression level of a gene of interest.

5. The method of claim 1 , wherein designing the second genome further comprises modifying the first genome based on the information from literature resources, experimental data, or any combination thereof.

6. The method of claim 5 , wherein the experimental data comprises data related to genes of essential function redundancies (EFR), or data obtained from a mutation study of the first genome, a genome related to the first genome, or any combination thereof.

7. The method of claim 1 , wherein at least one of the at least three fragments is a chromosome of the first or second genome, or a portion of a chromosome of the first or second genome.

8. The method of claim 1 , wherein testing the third genome for sufficiency to sustain viability of a cell comprises introducing the genome into a cell or a cell-like system.

9. The method of claim 1 , wherein modifying at least one fragment of the second genome in step (f) further comprises conducting a mutation study of the at least one fragment and modifying the at least one fragment at least partly based on the mutation study.

10. The method of claim 1 , wherein step (c) comprises dividing each of the first and second genomes into between 4 and 20 fragments.

11. The method of claim 1 , wherein at least one fragment of the second genome is present in an extrachromosomal genetic element.

12. The method of claim 1 , wherein the method generates a plurality of third genomes each having all of the at least three fragments.

13. The method of claim 1 , wherein the combining step comprises chemically synthesizing and assembling the fragments of the first and second genomes to generate the third genome.

14. The method of claim 1 wherein the first genome known to sustain viability of a cell has a size of up to 5 Mb.

15. The method of claim 1 wherein the genes related to the same biological process are grouped onto one fragment of the second genome.

16. The method of claim 1 further comprising grouping the genes related to the same biological process as contiguous modules a) in the at least one fragment of the second genome, or b) on the third genome.

17. The method of claim 16 wherein the same biological process is selected from the group consisting of: transport and catabolism ribosome biogenesis, protein export, DNA repair, transcription, translation, nucleotide biosynthesis, metabolism and salvage, glycolysis, proteolysis, membrane transport, rRNA modification, and tRNA modification.

18. The method of claim 16 wherein step (c) comprises dividing each of the first and second genomes into at least 20 fragments.

19. The method of claim 16 wherein the same biological process is selected from the group consisting of: transcription, RNA metabolism, translation, protein folding, protein export, a gene encoding RNA, ribosome biogenesis, rRNA modification, and tRNA modification.

20. The method of claim 1 wherein the same biological process is selected from the group consisting of: expression of genome information, preservation of genome information, cell membrane structure and function, and cytosolic metabolism.

Assignments (11)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2024
From: TELESIS BIO INC.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 066312/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 063967/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: SYNTHETIC GENOMICS, INC.
To: CODEX DNA, INC.
Reel/Frame 063967/0720 →
CHANGE OF NAME Recorded Jun 15, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 064122/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: HUTCHISON III, CLYDE A.; CHUANG, RAY-YUAN; NOSKOV, VLADIMIR N.; KARAS, BOGUMIL J.; WISE, KIM S.; SMITH, HAMILTON O.; GLASS, JOHN I.; MERRYMAN, CHUCK; VENTER, J. CRAIG; DING, LIN
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 063967/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: GIBSON, DANIEL G.; KANNAN, KRISHNA
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 063967/0577 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2021
From: CUTLER, ROBERT H
To: CODEX DNA, INC.
Reel/Frame 057731/0880 →
Continuity (3)
Continuation 15466675 · Mar 22, 2017
Provisional Application 62312398 · Mar 23, 2016
Related Publication 20210254046A1 · Aug 19, 2021
References Cited (55)
US 9267132B2 · Benders · 2016 [cited by applicant]
US 9434974B2 · Glass · 2016 [cited by applicant]
US 20070264688A1 · Venter et al. · 2007 [cited by applicant]
US 20070269862A1 · Glass et al. · 2007 [cited by applicant]
US 20080286871A1 · Holt · 2008 [cited by applicant]
US 20090275086A1 · Gibson et al. · 2009 [cited by applicant]
US 20110053273A1 · Benders et al. · 2011 [cited by applicant]
WO WO9831837A1 · 1998 [cited by applicant]
WO WO2006119066A2 · 2006 [cited by applicant]
WO WO2007047148A1 · 2007 [cited by applicant]
WO WO2008016380A2 · 2008 [cited by applicant]
WO WO2008024129A2 · 2008 [cited by applicant]
WO WO2010102257A2 · 2010 [cited by applicant]
Chromosome 15—Wikipedia pp. 1-13; downloaded Aug. 23, 2024. [cited by examiner]
A. Svoboda, Microbiology, 1978. [cited by applicant]
Abdel-Banat., et al., “Yeast,” 2010, vol. 27, 1 Page. [cited by applicant]
Adey, et al., Genome Biology, 2010, vol. 11, p. R119. [cited by applicant]
Boeke, et al., Molecular & General Genetics (MGG), 1984, vol. 197, pp. 345-346. [cited by applicant]
Boeke JD et al., Methods Enzymol, (19870000), vol. 154, pp. 164-175. [cited by applicant]
Brouwer, et al., Nature, 2016, vol. 535, p. 566. [cited by applicant]
Extended European Search Report for European Application No. 17771095.1, mailed Jul. 24, 2019, 15 Pages. [cited by applicant]
Fleischmann, et al., Science, 1995, vol. 269, pp. 496-512. [cited by applicant]
Gibson D.G., et al., “Chemical Synthesis of the Mouse Mitochondrial Genome,” Nature Methods, Nature Pub. Group, Nov. 2010, vol. 07, No. 11, pp. 901-903, DOI: 10.1038/nmeth.1515, ISSN 15487091, XP055173787. [cited by applicant]
Gibson D.G., et al., “Complete Chemical Synthesis, Assembly, And Cloning Of A Mycoplasma Genitalium Genome,” Science, American Association for the Advancement of Science, US, Feb. 29, 2008, vol. 319, No. 5867, pp. 1215-… [cited by applicant]
Gibson D.G., et al., “Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome,” Science, Jul. 2, 2010, vol. 329, No. 5987, pp. 52-56, DOI: 10.1126/science.1190719, ISSN 0036-8075, XP055082599. [cited by applicant]
Gibson, et al., Proceedings of the National Academy of Sciences of the United States of America, 2008, vol. 105, pp. 20404-20409. [cited by applicant]
Gietz, et al., Nucleic Acids Research, 1992, vol. 20, p. 1425. [cited by applicant]
Glass J.I., et al., “Essential Genes Of A Minimal Bacterium,” Proceedings of the National Academy of Sciences of the United States of America, US, Jan. 10, 2006, vol. 103, No. 2, pp. 425-430, DOI: 10.1073/PNAS.051001310… [cited by applicant]
Haft, et al., Nucleic Acids Research, 2003, vol. 31, pp. 371-373. [cited by applicant]
Hill Abloom K, Molecular and Cellular Biology, 1987, vol. 7, No. 7, pp. 2397-2405. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2017/023666, mailed Oct. 4, 2018, 09 Pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2017/023666, mailed Jul. 6, 2017, 12 Pages. [cited by applicant]
Jensen, et al., Journal of Clinical Microbiology, 1996, vol. 34, pp. 286-291. [cited by applicant]
Karas B.J., et al., “Direct Transfer of Whole Genomes From Bacteria to Yeast,” Nature Methods, Mar. 31, 2013, vol. 10, No. 5, pp. 410-412, DOI: 10.1038/nmeth.2433, ISSN 1548-7091, XP055089021. [cited by applicant]
Karas B.J., et al., “Direct Transfer of Whole Genomes from Bacteria to Yeast, Suplementary Materials,” Nature Methods, New York, Mar. 31, 2013, vol. 10, No. 5, 19 Pages, DOI: 10.1038/nmeth.2433, ISSN 1548-7091, XP055602… [cited by applicant]
Karas B.J., et al., “Rescue of Mutant Fitness Defects using in Vitro Reconstituted Designer Transposons in Mycoplasma Mycoides,” Frontiers In Microbiology, Jul. 23, 2014, vol. 5, pp. 1-9, ISSN: 1664-302X, XP002792710. [cited by applicant]
Karas, et al., Nature Communications, 2015, vol. 6, p. 6925. [cited by applicant]
Kikuchi M., et al., “Novel Family Shuffling Methods for the in Vitro Evolution of Enzymes,” Gene, Elsevier, Amsterdam, NL, Aug. 5, 1999, vol. 236, No. 1, pp. 159-167, DOI: 10.1016/S0378-1119(99)00240-1, ISSN: 0378-1119,… [cited by applicant]
Kouprina, et al., Nature Protocols, 2008, vol. 3, pp. 371-377. [cited by applicant]
Lartigue, et al., Science, 2009, vol. 325, pp. 1693-1696. [cited by applicant]
Moriguchi, et al., PLoS One, 2016, vol. 11, p. e0148989. [cited by applicant]
Mushegian, et al., Proceedings of the National Academy of Sciences of the United States of America, 1996, vol. 93, pp. 10268-10273. [cited by applicant]
Nonklang, et al., Applied and Environmental Microbiology, 2008, vol. 74, p. 7514. [cited by applicant]
Noskov, et al., Nucleic Acids Research, 2010, vol. 38, pp. 2570-2576. [cited by applicant]
Sambrook, et al., Molecular Cloning, A Laboratory Manual, Cold Springs Harbor Press, 1989. [cited by applicant]
Sharma, et al., Journal of Nucleic Acids, 2010. [cited by applicant]
Singleton, et al., Dictionary of Microbiology and Molecular Biology, John Wiley & Sons, 1994. [cited by applicant]
Sleator R.D., “JCVI-syn3.0—A Synthetic Genome Stripped Bare!,” Bioengineered, Apr. 2, 2016, vol. 7, No. 2, pp. 53-56, ISSN 2165-5987, XP002792711. [cited by applicant]
Smith H.O., et al., “Generating A Synthetic Genome By Whole Genome Assembly: PhiX174 Bacteriophage From Synthetic Oligonucleotides,” Proceedings of the National Academy of Sciences of the United States of America, Dec. … [cited by applicant]
Stemmer W.P.C., et al., “Single-Step Assembly Of A Gene And Entire Plasmid From Large Nos. Of Oligodeoxyribonucleotides,” GENE, Oct. 15, 1995, vol. 164, No. 1, pp. 49-53, XP004041916. [cited by applicant]
Strand, et al., PloS One, 2014, vol. 9, p. e90372. [cited by applicant]
Suzuki, et al., Nature Methods, 2011. [cited by applicant]
Young L., et al., “Two-step Total Gene Synthesis Method,” Nucleic Acids Research, Published Online on Apr. 15, 2004, vol. 32, No. 7, E59, pp. 1-6. [cited by applicant]
Yung et al., Journal of bacteriology, 2015, vol. 197, p. 3160. [cited by applicant]
AU Office Action in Australian Application No. 2017238212, dated Aug. 23, 2022, 6 pages. [cited by applicant]